Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
JSPR Jasper Therapeutics
- 21.090
- -0.290-1.36%
Close Jan 2 16:00 ET
- 21.090
- 0.0000.00%
Post 18:25 ET
316.38MMarket Cap-4.44P/E (TTM)
22.520High21.000Low296.16KVolume21.530Open21.380Pre Close6.43MTurnover2.95%Turnover RatioLossP/E (Static)15.00MShares31.01052wk High3.78P/B211.68MFloat Cap6.61252wk Low--Dividend TTM10.04MShs Float188.800Historical High--Div YieldTTM7.11%Amplitude3.862Historical Low21.698Avg Price1Lot Size
About Jasper Therapeutics Company
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Company Profile
SymbolJSPR
Company NameJasper Therapeutics
Listing DateJan 10, 2020
Founded2018
CEOMr. Ronald A. Martell
MarketNASDAQ
Employees45
Fiscal Year Ends12-31
Address2200 Bridge Parkway,Suite 102
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-549-1400
Company Executives
- Name
- Position
- Salary
- Ronald A. Martell
- Director, President and Chief Executive Officer
- 3.37M
- Jeet Mahal
- Chief Operating Officer
- 1.18M
- Herbert C. Cross
- Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
- 643.12K
- Dr. Edwin Jonathan Tucker, M.D.
- Chief Medical Officer
- 977.73K
- Thomas G. Wiggans
- Chairman of the Board
- 76.47K
- Dr. Judith Shizuru, M.D.,PhD
- Director
- 357.71K
- Dr. Svetlana Lucas, PhD
- Director
- --
- Dr. Scott C. Brun, M.D.
- Independent Director
- 136.57K
- Vishal Kapoor
- Independent Director
- 266.47K
- Christian W. Nolet
- Independent Director
- 126.41K
- Kurt von Eer, C.F.A.
- Independent Director
- 128.21K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.